Steven Miller

(Dr. Steven Miller Ph.D.)

Currently holds a position at Catalyst Pharmaceuticals Inc

Positions

Position Company Period
Chief Operating Officer, Chief Scientific Officer Catalyst Pharmaceuticals Inc Jan. 21, 2011 -
Steven Miller's trades of Catalyst Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-12-11 2024-12-10 S Sale
50,000 -6.8%
21.93
USD 1,096,350
50,000 -6.8% 21.93 USD 1,096,350
2024-08-22 2024-08-20 S Sale
50,000 -6.9%
20.59
USD 1,029,250
50,000 -6.9% 20.59 USD 1,029,250
2024-08-22 2024-08-20 S Sale
50,000 -6.5%
20.21
USD 1,010,600
50,000 -6.5% 20.21 USD 1,010,600
2024-08-22 2024-08-20 S Sale
50,000 -6.1%
20.26
USD 1,013,050
50,000 -6.1% 20.26 USD 1,013,050
2023-12-07 2023-12-05 S Sale
40,000 -5.8%
14.24
USD 569,600
40,000 -5.8% 14.24 USD 569,600
2022-11-23 2022-11-23 S Sale
20,000 -3.5%
17.34
USD 346,740
20,000 -3.5% 17.34 USD 346,740
2022-11-23 2022-11-21 S Sale
80,000 -12.2%
15.28
USD 1,222,080
80,000 -12.2% 15.28 USD 1,222,080
2022-09-15 2022-09-13 S Sale
75,000 -10.3%
16.85
USD 1,263,450
75,000 -10.3% 16.85 USD 1,263,450
2022-09-15 2022-09-13 S Sale
7,933 -1.1%
17.11
USD 135,742
7,933 -1.1% 17.11 USD 135,742
2022-09-15 2022-09-13 S Sale
25,000 -3.3%
17.01
USD 425,175
25,000 -3.3% 17.01 USD 425,175
2022-08-19 2022-08-18 S Sale
31,425 -4.0%
13.43
USD 422,163
31,425 -4.0% 13.43 USD 422,163
2022-08-19 2022-08-18 S Sale
118,575 -13.5%
13.56
USD 1,607,758
118,575 -13.5% 13.56 USD 1,607,758
2021-08-26 2021-08-25 S Sale
80,000 -9.7%
5.56
USD 444,640
80,000 -9.7% 5.56 USD 444,640
2021-08-17 2021-08-13 S Sale
40,963 -5.5%
6.09
USD 249,416
40,963 -5.5% 6.09 USD 249,416
// ... existing code ... // ... rest of the file ...